Benjamin M Ellingson

发表

Spatially quantifying microscopic tumor invasion and proliferation using a voxel‐wise solution to a glioma growth model and serial diffusion MRI

Benjamin M Ellingson, Peter S LaViolette, Scott D Rand, 2011, Magnetic resonance in medicine.

Nonlinear registration of diffusion‐weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab

Benjamin M Ellingson, Timothy F Cloughesy, Albert Lai, 2012, Magnetic resonance in medicine.

Radiologic progression of glioblastoma under therapy—an exploratory analysis of AVAglio

Michael Platten, Alexander Radbruch, Martin Bendszus, 2018, Neuro-oncology.

Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)‐MRI estimates of cerebral blood volume (CBV) in human gliomas

Benjamin M Ellingson, Timothy F Cloughesy, Albert Lai, 2012, Journal of magnetic resonance imaging : JMRI.

Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial.

Benjamin M Ellingson, Timothy F Cloughesy, Albert Lai, 2014, Radiology.

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

Eudocia Q Lee, Benjamin M Ellingson, Timothy F Cloughesy, 2015, Clinical Cancer Research.

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

Marion Smits, Bradley J Erickson, Jayashree Kalpathy-Cramer, 2015, Neuro-oncology.

Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.

Benjamin M Ellingson, Timothy F Cloughesy, Albert Lai, 2012, Neuro-oncology.

Pros and cons of current brain tumor imaging.

Benjamin M Ellingson, Timothy F Cloughesy, Patrick Y Wen, 2014, Neuro-oncology.

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

Zhaoshi Jiang, Somasekar Seshagiri, Franklin Peale, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab.

Paul S Mischel, Benjamin M Ellingson, Timothy F Cloughesy, 2011, Neuro-oncology.

Simulation, phantom validation, and clinical evaluation of fast pH‐weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST‐EPI) in glioma at 3 T

Benjamin M Ellingson, Timothy F Cloughesy, Albert Lai, 2016, NMR in biomedicine.

Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy

Michael E Phelps, Benjamin M Ellingson, Timothy F Cloughesy, 2014, Clinical Cancer Research.

Response Assessment and Magnetic Resonance Imaging Issues for Clinical Trials Involving High-Grade Gliomas

Benjamin M Ellingson, Jerrold L Boxerman, J. Boxerman, 2015, Topics in magnetic resonance imaging : TMRI.

18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study

Benjamin M Ellingson, Timothy F Cloughesy, Albert Lai, 2018, Journal of Neuro-Oncology.

Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.

Benjamin M Ellingson, Timothy F Cloughesy, Albert Lai, 2013, Neuro-oncology.

Longitudinal Patterns in Clinical and Imaging Measurements Predict Residual Survival in Glioblastoma Patients

William Hsu, Benjamin M Ellingson, Timothy F Cloughesy, 2018, Scientific Reports.

pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI.

Debiao Li, Benjamin M Ellingson, Timothy F Cloughesy, 2015, Neuro-oncology.

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.

Naoya Hashimoto, Enrico Franceschi, Ashok Panigrahy, 2015, The Lancet. Oncology.

Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma

Benjamin M Ellingson, Whitney B Pope, Jerrold L Boxerman, 2017, American journal of clinical oncology.

18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.

Michael E Phelps, Benjamin M Ellingson, Timothy F Cloughesy, 2012, Neuro-oncology.

Emerging techniques and technologies in brain tumor imaging.

A Gregory Sorensen, Martin Bendszus, Benjamin M Ellingson, 2014, Neuro-oncology.